Low-level laser therapy for prevention of noise-induced hearing loss in rats

Neurosci Lett. 2015 May 19:595:81-6. doi: 10.1016/j.neulet.2015.03.031. Epub 2015 Mar 19.

Abstract

Noninvasive low-level laser therapy (LLLT) is neuroprotective, but the mechanism of this effect is not fully understood. In this study, the use of LLLT as a novel treatment for noise-induced hearing loss (NIHL) is investigated. Sprague-Dawley rats were exposed to intense noise and their right ears were irradiated with an 808nm diode laser at an output power density of 110 or 165mW/cm(2) for a 30min period for 5 consecutive days. Measurement of the auditory brainstem response revealed an accelerated recovery of auditory function in the groups treated with LLLT compared with the non-treatment group at days 2, 4, 7 and 14 after noise exposure. Morphological observations also revealed a significantly higher outer hair cell survival rate in the LLLT groups. Immunohistochemical analyses for inducible nitric oxide synthase (iNOS) and cleaved caspase-3 were used to examine oxidative stress and apoptosis. Strong immunoreactivities were observed in the inner ear tissues of the non-treatment group, whereas these signals were decreased in the LLLT group at 165mW/cm(2) power density. Our findings suggest that LLLT has cytoprotective effects against NIHL via the inhibition of iNOS expression and apoptosis.

Keywords: Cleaved caspase-3; Inducible nitric oxide synthase; Low-level laser therapy; Noise-induced hearing loss.

MeSH terms

  • Animals
  • Apoptosis / radiation effects
  • Caspase 3 / metabolism
  • Evoked Potentials, Auditory, Brain Stem
  • Hair Cells, Auditory, Outer / pathology
  • Hair Cells, Auditory, Outer / radiation effects
  • Hearing Loss / etiology
  • Hearing Loss / pathology
  • Hearing Loss / physiopathology
  • Hearing Loss / prevention & control*
  • Low-Level Light Therapy*
  • Male
  • Nitric Oxide Synthase Type II / metabolism
  • Noise / adverse effects*
  • Oxidative Stress / radiation effects
  • Rats, Sprague-Dawley

Substances

  • Nitric Oxide Synthase Type II
  • Caspase 3